"/> Novus Biologicals™ Peptide bloquant d’anticorps AT… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps ATF6

Réf. : BL-RE-044091Réf. fabricant : 18246648 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
22926
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76675. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the carboxy terminus of human ATF6.

Points forts

Source

Synthetic

(Accession #: NP_031374) The ATF6 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-044091
Réf. fabricant18246648
Gene ID (Entrez)22926
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76675. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneactivating transcription factor 6, Activating transcription factor 6 alpha, atf6 a, ATF6A, ATF6-alpha, cAMP-dependent transcription factor ATF-6 alpha, cyclic AMP-dependent transcription factor ATF-6 alpha
Symbole de gène(s)ATF6
Type de produitATF6
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the carboxy terminus of human ATF6
Une question, une configuration particulière ?
Contactez-nous pour un devis.